An evaluation of orcein methods for demonstrating hepatitis B surface antigen and copper-associated protein in human liver.
Difficulties were encountered with the orcein method currently being used to demonstrate hepatitis B surface antigen and copper-associated protein in the liver when a new batch of dye was introduced. A survey of published material produced a plethora of methods with many contradictory recommendations. A number of methods and a variety of orceins were compared to determine which methods and orcein solutions would give the most consistent results. Two methods gave equally satisfactory results and can be recommended for routine use in screening paraffin sections of liver for hepatitis B surface antigen and copper-associated protein.
D006509:Hepatitis B / Q000473:pathology; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006651:Histocytochemistry / Q000379:methods; D006801:Humans; D008099:Liver / Q000276:immunology* / Q000473:pathology; D008103:Liver Cirrhosis / Q000473:pathology; D008668:Metallothionein / Q000032:analysis*; D010078:Oxazines; D013194:Staining and Labeling
D006514:Hepatitis B Surface Antigens; D010078:Oxazines; C007121:copper thionein; C002313:PAcein; D008668:Metallothionein